AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
AEMD Stock Price Drops 24% Following Disappointing Earnings Report
ByAinvest
Friday, Jun 27, 2025 6:51 pm ET1min read
AEMD stock plummeted 24% after the company reported earnings that failed to meet market expectations. Investors are disappointed with the financial results, leading to uncertainty about the company's future prospects. Wall Street analysts forecast an average target price of $4.50, implying an upside of 131.96% from the current price. The estimated GF Value for Aethlon Medical Inc is $99.64, suggesting a 5036.08% upside.
Aethlon Medical Inc (AEMD) stock experienced a significant drop of 24% following the release of its earnings report for the full year ended March 31, 2025. The company reported a net loss of USD 13.39 million, up from USD 12.21 million a year ago. The basic loss per share from continuing operations was USD 8.58, compared to USD 38.87 a year ago [1].The earnings report fell short of market expectations, with analysts projecting an earnings per share of -$1.09. The stock's price target range provided by Wall Street analysts was between USD 4.50 and USD 56.00, with an average target price of USD 30.25, suggesting an upside of 1,628.57% from the current price of USD 1.75 [2].
GuruFocus estimates an impressive 5,036.08% upside for AEMD based on its GF Value metric, which is calculated using historical trading multiples, past business growth, and future performance forecasts. The estimated GF Value for AEMD is USD 99.64 over the next year [3].
Investors are concerned about the company's future prospects, and the market's reaction to the earnings report will be closely monitored. Despite the disappointing results, the consensus recommendation from brokerage firms is currently "Outperform," indicating a favorable outlook among analysts [2].
References:
[1] https://www.marketscreener.com/quote/stock/AETHLON-MEDICAL-INC-22881435/news/Aethlon-Medical-Inc-Reports-Earnings-Results-for-the-Full-Year-Ended-March-31-2025-50356636/
[2] https://www.gurufocus.com/news/2948836/aethlon-medical-aemd-poised-to-report-earnings-with-consensus-expectations-aemd-stock-news
[3] https://www.gurufocus.com/news/2949288/aethlon-medical-aemd-reports-widerthanexpected-annual-loss
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet